3 results
Approved WMOCompleted
Our study tries to identify the ideal sclerosant dosage for the ClariVein® system in order to occlude the GSV permanently. By choosing the lowest dose with the same anatomical success rate, we achieve a safe treatment which also gives us the…
Approved WMORecruiting
To assess to efficacy of locally applied tacrolimus suppositories compared to beclomethason suppositories in patients with recurrent or refactory ulcerative proctitis.
Approved WMORecruiting
This study seeks to demonstrate the effectiveness and safety of the Non-Valved Conduit on the basis of infection. The rationale for infection resistance with the conduit is that Biointegral Surgical No-React® treated products have a well-documented…